Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | -1.06% | +4.94% | -6.79% |
05:57pm | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
15/05 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.79% | 19Cr | |
+33.15% | 4.95TCr | |
+2.02% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+12.07% | 2.66TCr | |
-22.58% | 1.86TCr | |
+8.32% | 1.32TCr | |
+30.32% | 1.25TCr | |
+24.00% | 1.21TCr |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- SVB Securities Adjusts Price Target on Abeona Therapeutics to $5 From $1, Maintains Market Perform Rating